Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ototoxicity 1 Neoplasms 1

Interventions

Exercise 8 Standard of Care 5 trametinib 3 tislelizumab 3 Radiotherapy 3 Radiosurgery 3 Palliative Care 3 Paclitaxel 3 Gemcitabine 3 130-nm albumin-bound paclitaxel 3 trastuzumab deruxtecan 2 cemiplimab 2 Therapeutics 2 Surveys and Questionnaires 2 Resistance Training 2 Oxaliplatin 2 Nivolumab 2 Maintenance 2 Immune Checkpoint Inhibitors 2 Drug Therapy 2 Cisplatin 2 Carboplatin 2 vedolizumab 1 toripalimab 1 surufatinib 1 sparsentan 1 sintilimab 1 semaglutide 1 posaconazole 1 pomalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Neoplasms × Audiometry × Clear all

NCT06957132 2025-05-04

RISP-OTOTOX

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Not yet recruiting

Ototoxicity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡